Routes of Administration Subcutaneous injection (community protocol): Community sources describe the abdomen, love handles, and thighs areas with subcutaneous fat as the typical injection sites, at a volume of approximately 0.1 mL using a 29-31 gauge insulin syringe
PMID 22137594
They are often chosen by people who want a supportive, skin-comfort-focused active that can help the look of firmness and resilience without the same reputation for dryness, peeling or irritation
The glucose-dependency of GLP-1s insulinotropic effect it only amplifies insulin secretion when blood glucose is elevated is a key pharmacological property that distinguishes GLP-1 from non-incretin insulin secretagogues in research models
Food and Drug Administration (FDA) have raised concerns about a potential link between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicide or suicide attempts
The American Academy of Family Physicians confirms that oral doses of 1,000 to 2,000 mcg daily can correct both anemia and neurologic symptoms in most deficient patients